Inhibition of HIV-1 replication by small interfering RNAs directed against Glioma Pathogenesis Related Protein (GliPR) expression

Retrovirology

Volumn 7, Issue , 2010, Pages

  Capalbo, Gianni ^a   Müller Kuller, Thea ^a   Dietrich, Ursula ^b   Hoelzer, Dieter ^a   Ottmann, Oliver G ^a   Scheuring, Urban J ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b INSTITUTE FOR TUMOR BIOLOGY AND EXPERIMENTAL THERAPY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD59 ANTIGEN; CYCLIC AMP DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT; GENE PRODUCT; GLIOMA PATHOGENESIS RELATED PROTEIN; PROTEIN KINASE C ALPHA; SMALL INTERFERING RNA; STEROID RECEPTOR COACTIVATOR 3; SYNDECAN 1; SYNDECAN 2; UNCLASSIFIED DRUG; ANTIVIRUS AGENT; BIOLOGICAL PRODUCT; GLIPR1 PROTEIN, HUMAN; NERVE PROTEIN; TUMOR PROTEIN;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE REPRESSION; GENE SEQUENCE; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PROTEIN INTERACTION; SEQUENCE HOMOLOGY; T LYMPHOCYTE; UPREGULATION; VIRUS REPLICATION; CELL LINE; DNA MICROARRAY; DRUG ANTAGONISM; GENE EXPRESSION PROFILING; GENETICS; PHYSIOLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ANTIVIRAL AGENTS; BIOLOGICAL PRODUCTS; CELL LINE; GENE EXPRESSION PROFILING; HIV-1; HUMANS; NEOPLASM PROTEINS; NERVE TISSUE PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, SMALL INTERFERING; VIRUS REPLICATION;

EID: 77950405709     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-7-26     Document Type: Article

References (51)

1. Agbottah ET, Traviss C, McArdle J, Karki S, St Laurent GC, Kumar A. Nuclear Factor 90(NF90) targeted to TAR RNA inhibits transcriptional activation of HIV-1. Retrovirology 2007, 4:41. 10.1186/1742-4690-4-41, 1910605, 17565699.
2. Lama J, Planelles V. Host factors influencing susceptibility to HIV infection and AIDS progression. Retrovirology 2007, 4:52. 10.1186/1742-4690-4-52, 1978541, 17651505.
3. Vardabasso C, Manganaro L, Lusic M, Marcello A, Giacca M. The histone chaperone protein Nucleosome Assembly Protein-1 (hNAP-1) binds HIV-1 Tat and promotes viral transcription. Retrovirology 2008, 5:8. 10.1186/1742-4690-5-8, 2266780, 18226242.
4. Ye Y, De Leon J, Yokoyama N, Naidu Y, Camerini D. DBR1 siRNA inhibition of HIV-1 replication. Retrovirology 2005, 2:63. 10.1186/1742-4690-2-63, 1266399, 16232320.
5. Brass AL, Dykxhoorn DM, Benita Y, Yan N, Engelman A, Xavier RJ, Lieberman J, Elledge SJ. Identification of host proteins required for HIV infection through a functional genomic screen. Science 2008, 319:921-926. 10.1126/science.1152725, 18187620.
6. Bosinger SE, Hosiawa KA, Cameron MJ, Persad D, Ran L, Xu L, Boulassel MR, Parenteau M, Fournier J, Rud EW, Kelvin DJ. Gene expression profiling of host response in models of acute HIV infection. J Immunol 2004, 173:6858-6863.
7. Geiss GK, Bumgarner RE, An MC, Agy MB, van 't Wout AB, Hammersmark E, Carter VS, Upchurch D, Mullins JI, Katze MG. Large-scale monitoring of host cell gene expression during HIV-1 infection using cDNA microarrays. Virology 2000, 266:8-16. 10.1006/viro.1999.0044, 10612655.
8. Krishnan V, Zeichner SL. Host cell gene expression during human immunodeficiency virus type 1 latency and reactivation and effects of targeting genes that are differentially expressed in viral latency. J Virol 2004, 78:9458-9473. 10.1128/JVI.78.17.9458-9473.2004, 506933, 15308739.
9. Scheuring UJ, Corbeil J, Mosier DE, Theofilopoulos AN. Early modification of host cell gene expression induced by HIV-1. Aids 1998, 12:563-570. 10.1097/00002030-199806000-00004, 9583595.
10. Yin J, Chen MF, Finkel TH. Differential gene expression during HIV-1 infection analyzed by suppression subtractive hybridization. Aids 2004, 18:587-596. 10.1097/00002030-200403050-00002, 15090763.
11. Cicala C, Arthos J, Selig SM, Dennis G, Hosack DA, Van Ryk D, Spangler ML, Steenbeke TD, Khazanie P, Gupta N, Yang J, Daucher M, Lempicki RA, Fauci AS. HIV envelope induces a cascade of cell signals in non-proliferating target cells that favor virus replication. Proc Natl Acad Sci USA 2002, 99:9380-9385. 10.1073/pnas.142287999, 123149, 12089333.
12. de la Fuente C, Santiago F, Deng L, Eadie C, Zilberman I, Kehn K, Maddukuri A, Baylor S, Wu K, Lee CG, Pumfery A, Kashanchi F. Gene expression profile of HIV-1 Tat expressing cells: a close interplay between proliferative and differentiation signals. BMC Biochem 2002, 3:14. 10.1186/1471-2091-3-14, 116586, 12069692.
13. Janket ML, Manickam P, Majumder B, Thotala D, Wagner M, Schafer EA, Collman RG, Srinivasan A, Ayyavoo V. Differential regulation of host cellular genes by HIV-1 viral protein R (Vpr): cDNA microarray analysis using isogenic virus. Biochem Biophys Res Commun 2004, 314:1126-1132. 10.1016/j.bbrc.2004.01.008, 14751250.
14. Joseph AM, Kumar M, Mitra D. Nef: "necessary and enforcing factor" in HIV infection. Curr HIV Res 2005, 3:87-94. 10.2174/1570162052773013, 15638726.
15. Goff SP. Genetic control of retrovirus susceptibility in mammalian cells. Annu Rev Genet 2004, 38:61-85. 10.1146/annurev.genet.38.072902.094136, 15568972.
16. Komano J, Futahashi Y, Urano E, Miyauchi K, Murakami T, Matsuda Z, Yamamoto N. The interaction of HIV-1 with the host factors. Jpn J Infect Dis 2005, 58:125-130.
17. Wahl SM, Greenwell-Wild T, Vazquez N. HIV accomplices and adversaries in macrophage infection. J Leukoc Biol 2006, 80:973-983. 10.1189/jlb.0306130, 16908514.
18. Murphy EV, Zhang Y, Zhu W, Biggs J. The human glioma pathogenesis-related protein is structurally related to plant pathogenesis-related proteins and its gene is expressed specifically in brain tumors. Gene 1995, 159:131-135. 10.1016/0378-1119(95)00061-A, 7607567.
19. Rich T, Chen P, Furman F, Huynh N, Israel MA. RTVP-1, a novel human gene with sequence similarity to genes of diverse species, is expressed in tumor cell lines of glial but not neuronal origin. Gene 1996, 180:125-130. 10.1016/S0378-1119(96)00431-3, 8973356.
20. Gingras MC, Margolin JF. Differential expression of multiple unexpected genes during U937 cell and macrophage differentiation detected by suppressive subtractive hybridization. Exp Hematol 2000, 28:65-76. 10.1016/S0301-472X(99)00126-5, 10658678.
21. Naruishi K, Timme TL, Kusaka N, Fujita T, Yang G, Goltsov A, Satoh T, Ji X, Tian W, Abdelfattah E, Men T, Watanabe M, Tabata K, Thompson TC. Adenoviral vector-mediated RTVP-1 gene-modified tumor cell-based vaccine suppresses the development of experimental prostate cancer. Cancer Gene Ther 2006, 13:658-663. 10.1038/sj.cgt.7700919, 16485011.
22. Ren C, Li L, Goltsov AA, Timme TL, Tahir SA, Wang J, Garza L, Chinault AC, Thompson TC. mRTVP-1, a novel p53 target gene with proapoptotic activities. Mol Cell Biol 2002, 22:3345-3357. 10.1128/MCB.22.10.3345-3357.2002, 133782, 11971968.
23. Ren C, Li L, Yang G, Timme TL, Goltsov A, Ren C, Ji X, Addai J, Luo H, Ittmann MM, Thompson TC. RTVP-1, a tumor suppressor inactivated by methylation in prostate cancer. Cancer Res 2004, 64:969-976. 10.1158/0008-5472.CAN-03-2592, 14871827.
24. Satoh T, Timme TL, Saika T, Ebara S, Yang G, Wang J, Ren C, Kusaka N, Mouraviev V, Thompson TC. Adenoviral vector-mediated mRTVP-1 gene therapy for prostate cancer. Hum Gene Ther 2003, 14:91-101. 10.1089/104303403321070793, 12614561.
25. Rosenzweig T, Ziv-Av A, Xiang C, Lu W, Cazacu S, Taler D, Miller CG, Reich R, Shoshan Y, Anikster Y, Kazimirsky G, Sarid R, Brodie C. Related to testes-specific, vespid, and pathogenesis protein-1 (RTVP-1) is overexpressed in gliomas and regulates the growth, survival, and invasion of glioma cells. Cancer Res 2006, 66:4139-4148. 10.1158/0008-5472.CAN-05-2851, 16618735.
26. Chilukamarri L, Hancock AL, Malik S, Zabkiewicz J, Baker JA, Greenhough A, Dallosso AR, Huang TH, Royer-Pokora B, Brown KW, Malik K. Hypomethylation and aberrant expression of the glioma pathogenesis-related 1 gene in Wilms tumors. Neoplasia 2007, 9:970-978. 10.1593/neo.07661, 2077888, 18030365.
27. Szyperski T, Fernandez C, Mumenthaler C, Wuthrich K. Structure comparison of human glioma pathogenesis-related protein GliPR and the plant pathogenesis-related protein P14a indicates a functional link between the human immune system and a plant defense system. Proc Natl Acad Sci USA 1998, 95:2262-2266. 10.1073/pnas.95.5.2262, 19313, 9482873.
28. Klessig DF, Durner J, Noad R, Navarre DA, Wendehenne D, Kumar D, Zhou JM, Shah J, Zhang S, Kachroo P, Trifa Y, Pontier D, Lam E, Silva H. Nitric oxide and salicylic acid signaling in plant defense. Proc Natl Acad Sci USA 2000, 97:8849-8855. 10.1073/pnas.97.16.8849, 34022, 10922045.
29. van Loon LC, Rep M, Pieterse CM. Significance of inducible defense-related proteins in infected plants. Annu Rev Phytopathol 2006, 44:135-162. 10.1146/annurev.phyto.44.070505.143425, 16602946.
30. Foster JA, Gerton GL. Autoantigen 1 of the guinea pig sperm acrosome is the homologue of mouse Tpx-1 and human TPX1 and is a member of the cysteine-rich secretory protein (CRISP) family. Mol Reprod Dev 1996, 44:221-229. 10.1002/(SICI)1098-2795(199606)44:2<221::AID-MRD11>3.0.CO;2-5, 9115720.
31. Novina CD, Murray MF, Dykxhoorn DM, Beresford PJ, Riess J, Lee SK, Collman RG, Lieberman J, Shankar P, Sharp PA. siRNA-directed inhibition of HIV-1 infection. Nat Med 2002, 8:681-686.
32. Scheuring UJ, Sabzevari H, Corbeil J, Theofilopoulos AN. Differential expression profiles of apoptosis-affecting genes in HIV-infected cell lines and patient T cells. Aids 1999, 13:167-175. 10.1097/00002030-199902040-00004, 10202822.
33. Selliah N, Shackelford J, Wang JF, Traynor F, Yin J, Finkel TH. T cell signaling and apoptosis in HIV disease. Immunol Res 2003, 27:247-260. 10.1385/IR:27:2-3:247, 12857972.
34. Zheng L, Yang Y, Guocai L, Pauza CD, Salvato MS. HIV Tat protein increases Bcl-2 expression in monocytes which inhibits monocyte apoptosis induced by tumor necrosis factor-alpha-related apoptosis-induced ligand. Intervirology 2007, 50:224-228. 10.1159/000100565, 2384232, 17356300.
35. Fernandez Larrosa PN, Croci DO, Riva DA, Bibini M, Luzzi R, Saracco M, Mersich SE, Rabinovich GA, Martínez Peralta L. Apoptosis resistance in HIV-1 persistently-infected cells is independent of active viral replication and involves modulation of the apoptotic mitochondrial pathway. Retrovirology 2008, 5:19. 10.1186/1742-4690-5-19, 2276517, 18261236.
36. Zhao C, Denison C, Huibregtse JM, Gygi S, Krug RM. Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways. Proc Natl Acad Sci USA 2005, 102:10200-10205. 10.1073/pnas.0504754102, 1177427, 16009940.
37. Moon HS, Yang JS. Role of HIV Vpr as a regulator of apoptosis and an effector on bystander cells. Mol Cells 2006, 21:7-20.
38. Perfettini JL, Castedo M, Roumier T, Andreau K, Nardacci R, Piacentini M, Kroemer G. Mechanisms of apoptosis induction by the HIV-1 envelope. Cell Death Differ 2005, 12(Suppl 1):916-923. 10.1038/sj.cdd.4401584, 15719026.
39. Milne TJ, Abbenante G, Tyndall JD, Halliday J, Lewis RJ. Isolation and characterization of a cone snail protease with homology to CRISP proteins of the pathogenesis-related protein superfamily. J Biol Chem 2003, 278:31105-31110. 10.1074/jbc.M304843200, 12759345.
40. Serrano RL, Kuhn A, Hendricks A, Helms JB, Sinning I, Groves MR. Structural analysis of the human Golgi-associated plant pathogenesis related protein GAPR-1 implicates dimerization as a regulatory mechanism. J Mol Biol 2004, 339:173-183. 10.1016/j.jmb.2004.03.015, 15123429.
41. Decroly E, Benjannet S, Savaria D, Seidah NG. Comparative functional role of PC7 and furin in the processing of the HIV envelope glycoprotein gp160. FEBS Lett 1997, 405:68-72. 10.1016/S0014-5793(97)00156-7, 9094426.
42. Tyagi M, Rusnati M, Presta M, Giacca M. Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans. J Biol Chem 2001, 276:3254-3261. 10.1074/jbc.M006701200, 11024024.
43. Teixe T, Nieto-Blanco P, Vilella R, Engel P, Reina M, Espel E. Syndecan-2 and -4 expressed on activated primary human CD4(+) lymphocytes can regulate T cell activation. Mol Immunol 2008, 45:2905-19. 10.1016/j.molimm.2008.01.033, 18342939.
44. Yu G, Shen FS, Sturch S, Aquino A, Glazer RI, Felsted RL. Regulation of HIV-1 gag protein subcellular targeting by protein kinase C. J Biol Chem 1995, 270:4792-4796. 10.1074/jbc.270.9.4792, 7876252.
45. Cartier C, Hemonnot B, Gay B, Bardy M, Sanchiz C, Devaux C, Briant L. Active cAMP-dependent protein kinase incorporated within highly purified HIV-1 particles is required for viral infectivity and interacts with viral capsid protein. J Biol Chem 2003, 278:35211-35219. 10.1074/jbc.M301257200, 12842892.
46. Jakobovits A, Rosenthal A, Capon DJ. Trans-activation of HIV-1 LTR-directed gene expression by tat requires protein kinase C. Embo J 1990, 9:1165-1170. 551792, 2182321.
47. Kino T, Slobodskaya O, Pavlakis GN, Chrousos GP. Nuclear receptor coactivator p160 proteins enhance the HIV-1 long terminal repeat promoter by bridging promoter-bound factors and the Tat-P-TEFb complex. J Biol Chem 2002, 277:2396-2405. 10.1074/jbc.M106312200, 11704662.
48. Nguyen DH, Hildreth JE. Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts. J Virol 2000, 74:3264-3272. 10.1128/JVI.74.7.3264-3272.2000, 111827, 10708443.
49. Charneau P, Alizon M, Clavel F. A second origin of DNA plus-strand synthesis is required for optimal human immunodeficiency virus replication. J Virol 1992, 66:2814-2820. 241038, 1560526.
50. Osborne R, Mason H, Browning M, Mitchell R, Jarrett W. A sensitive assay for detection and measurement of neutralising antibody to human immunodeficiency virus. J Virol Methods 1992, 39:15-26. 10.1016/0166-0934(92)90121-S, 1430060.
51. Scheuring UJ, Pfeifer H, Wassmann B, Bruck P, Atta J, Petershofen EK, Gehrke B, Gschaidmeier H, Hoelzer D, Ottmann OG. Early minimal residual disease (MRD) analysis during treatment of Philadelphia chromosome/Bcr-Abl-positive acute lymphoblastic leukemia with the Abl-tyrosine kinase inhibitor imatinib (STI571). Blood 2003, 101:85-90. 10.1182/blood-2002-02-0360, 12393581.